KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Globus Medical (GMED) EBT (2016 - 2025)

Globus Medical's EBT history spans 15 years, with the latest figure at $169.2 million for Q4 2025.

  • For Q4 2025, EBT rose 586.07% year-over-year to $169.2 million; the TTM value through Dec 2025 reached $605.1 million, up 401.41%, while the annual FY2025 figure was $605.1 million, 401.21% up from the prior year.
  • EBT reached $169.2 million in Q4 2025 per GMED's latest filing, up from $144.0 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $188.2 million in Q2 2025 to a low of -$8.6 million in Q1 2024.
  • Average EBT over 5 years is $66.2 million, with a median of $57.1 million recorded in 2021.
  • The largest YoY upside for EBT was 2149.78% in 2024 against a maximum downside of 113.61% in 2024.
  • A 5-year view of EBT shows it stood at $24.2 million in 2021, then skyrocketed by 173.75% to $66.4 million in 2022, then crashed by 62.33% to $25.0 million in 2023, then fell by 1.31% to $24.7 million in 2024, then surged by 586.07% to $169.2 million in 2025.
  • Per Business Quant, the three most recent readings for GMED's EBT are $169.2 million (Q4 2025), $144.0 million (Q3 2025), and $188.2 million (Q2 2025).